the microsampling blog / Immunosuppressants (2)

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

by Neoteryx | 2 min read

When using immunosuppressive therapy drugs as an organ transplant recipient, it is crucial to effectively and consistently monitor drug levels. This requires therapeutic drug monitoring and an understanding of requirements …

Read Story

by Neoteryx | 2 min read

Therapeutic drug monitoring (TDM) immunosuppressants are a critical component of post-tissue and organ transplantation therapy. This is because ISP drugs have high intra- and inter-subject variability and a narrow therapeutic …

Read Story

by Neoteryx | 2 min read

When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy. The goal is to attain an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present …

Read Story

by Neoteryx | 2 min read

For many organ transplant patients, immunosuppressant monitoring is a fact of life. But that does not mean that it cannot be significantly improved. For proof, look no further than the …

Read Story

by Neoteryx | 3 min read

At the 2019 meeting of the American Transplant Congress, held this year in Boston, scientists from the Oslo University Hospital, Rikshospitalet presented exciting findings regarding more patient-centered AUC-monitoring of tacrolimus, …

Read Story

by Neoteryx | 2 min read

Capillary blood microsampling is a technique that has made collection and analysis of small, exact volumes of liquid matrices much simpler. Through capillary blood microsampling, tacrolimus monitoring has potentially become …

Read Story
Content not found

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog